How many studies have been conducted on Amphiregulin?

BiohacksAI has indexed 300 PubMed studies on Amphiregulin, including 1 randomized controlled trials (RCTs). 28% of studies involve human subjects.

What are the main research areas for Amphiregulin?

The primary research domains for Amphiregulin are 🔬 Oncology, 🫘 Kidney, 🔬 Inflammation. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Amphiregulin

An autocrine growth factor and mitogen for a broad range of target cells including EPITHELIAL CELLS; FIBROBLASTS and immune cells. It occurs as a membrane-bound protein that can be cleaved to release an active secreted form.

300+ PubMed studies analyzed · 1 RCTs · Evidence Score: 46.4

Research Domains

Amphiregulin has been studied across 18 research domains including 🔬 Oncology, 🫘 Kidney, 🔬 Inflammation, 🛡️ Immunity, 🧬 Hormones. The primary research focus is 🔬 Oncology with 39% of studies addressing this area.

Loading evidence profile...

This evidence profile for Amphiregulin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.